Results 201 to 204 of about 2,075,366 (204)
Some of the next articles are maybe not open access.
Vutrisiran in ATTR-CM: Questions on Combination Therapy and Early Biomarker Kinetics.
Journal of the American College of CardiologyZhiwen Zhang, Quan Guo, Muwei Li
semanticscholar +1 more source
SGLT2 inhibitors and Tafamidis in ATTR-CM: Promise or premature optimism?
Journal of CardiologyAbdülmelik Birgün +2 more
semanticscholar +1 more source
SEX DIFFERENCES IN THE PERFORMANCE OF THE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) RISK SCORE
Journal of the American College of CardiologyMichel Chedid El Helou +8 more
openaire +1 more source
HELIOS-B: Health benefits of vutrisiran for ATTR-CM may increase over time
Medicom Conference Report HFA 2025openaire +1 more source

